SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950142-02-000417
Filing Date
2002-05-06
Accepted
2002-05-06 17:23:34
Documents
3
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS EC, L.L.C.PERSEUS-SOROS BIOPHARMACEUTICAL FUND LPPERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCSFM PARTICIPATION, LPSOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13-G ALLOS THERAPEUTICS, INC. sc13g-allos.txt SC 13G 38004
3 EXHIBIT 1 JOINT FILING AGREEMENT ex1sc13g-allos.txt EX-99 5127
4 EXHIBIT 2 POWER OF ATTORNEY ex2sc13g-allos.txt EX-24 2750
  Complete submission text file 0000950142-02-000417.txt   48516
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 7000 NORTH BROADWAY SUITE 400 DENVER CO 80221
Business Address 7000 NORTH BROADWAY SUITE 400 DENVER CO 80221 3034266262
ALLOS THERAPEUTICS (Subject) CIK: 0001097264 (see all company filings)

IRS No.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60251 | Film No.: 02635208
SIC: 2834 Pharmaceutical Preparations